at Zacks.com (Jan 22, 2015)
Shares of Arena Pharmaceuticals (ARNA -1.4%) are halted pending news that U.S. regulators have approved its weight-loss drug Belviq - formerly known as lorcaserin. The announcement is expected but notable nonetheless, due to the fact that it will be the first new prescription diet pill to be cleared for sale in the U.S. in over 13 years.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Jan 16, 2015)
at Zacks.com (Jan 15, 2015)
at Benzinga.com (Jan 14, 2015)
at Benzinga.com (Jan 13, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs